Relationshi pwith Neuropathic pain and immunology

Not Applicable

• Conditions: peripheral neuropathic pain

• Registration Number: JPRN-UMIN000048989
• Lead Sponsor: Department of Anesthesiology & Critical Care Medicine Faculty of Medicine, Saga University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-11-07
• Study Completion: 2023-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Not provided

Exclusion Criteria

1)Pregnant patients or patients of childbearing potential 2) Patients who declared non-participation in the study 3) Patients with significant psychosocial factors 4) Patients who are unable to communicate 5) Patients with coexisting diseases that may cause neurological disorders such as diabetes mellitus (6) Patients who are in court or in litigation due to accidents

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
blood levels of cytokines (IL-27, IL-10, TNFarfa, IL-1beta) and Mincle before and after treatment

Secondary Outcome Measures

Name	Time	Method
VAS (Visual Analogue Scale) measurement, temperature/cold pain measurement, pain-responsive current, and minimal sensing current using a quantitative sensory/algesic analyzer before and after treatment